SSRIs for premenstrual dysphoric disorder

Drug and Therapeutics Bulletin

Volumn 40, Issue 9, 2002, Pages 70-72

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FATIGUE; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; NAUSEA; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; RATING SCALE; SEROTONINERGIC TRANSMISSION; SEXUAL DYSFUNCTION; SWEATING; VERTIGO; XEROSTOMIA;

EID: 0036738053     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2002.40970     Document Type: Article

References (22)

1. O'Brien PMS. Premenstrual syndrome. Oxford: Blackwell Scientific Publications, 1987.
2. Managing the premenstrual syndrome
3. Wittchen H-U et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psych Med 2002; 32: 119-32.
4. Endicott J et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999; 8: 663-79.
5. Dimmock PW et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356: 1131-6.
6. Steiner M et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1996; 332: 1529-34.
7. Stone AB et al. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991; 52: 290-3.
8. Wood SH et al. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 1992; 80: 339-44.
9. Özeren SA et al. Fluoxetine in the treatment of premenstrual syndrome. Eur J Obstet Gynecol Reprod Biol 1997; 73: 167-70.
10. Menkes DB et al. Fluoxetine treatment of severe premenstrual syndrome. BMJ 1992; 305: 346-7.
11. Su T-P et al. Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 1997; 16: 346-56.
12. Yonkers KA et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: a randomized controlled trial. JAMA 1997; 278: 983-8.
13. Young SA et al. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 1998; 59: 76-80.
14. Jermain DM et al. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study. Arch Fam Med 1999; 8: 328-32.
15. Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997; 58: 399-402.
16. Eriksson E et al. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995; 12: 167-76.
17. Wikander I et al. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998; 18: 390-8.
18. Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1994; 55: 332-5.
19. Sundblad C et al. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. Eur Neuropsychopharmacology 1997; 7: 201-6.
20. Steiner M et al. Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria. Obstet Gynecol 1997; 90: 590-5.
21. Withdrawing patients from antidepressants